Company / Income Tax
GYRE THERAPEUTICS, INC. Income Tax History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$4.6M
FY2025
5-year range
$4.6M / $5.3M
FY2022-FY2025
Trend
-14.4%
vs FY2024
Sector context
#51 of 204
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s income tax of $5M is higher than 75% of companies in the Health Care sector (FY2025). Improved from $5M to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of -3.7%. Top quartile in the Health Care sector.
Improved from $5M to $5M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -3.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 204This company $4.6M Sector average $118.7M
▼
-96.2% below sector average
Key checks
Key Insights
- 3-year CAGR of -3.7%, indicating a declining trend.
- In FY2025, income tax decreased 14.4% year-over-year.
- Ranks #51 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.6M | -14.4% |
| FY2024 | $5.3M | +4.4% |
| FY2023 | $5.1M | +0.0% |
| FY2022 | $5.1M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026